Written by SmartSense
Our customer-proven solutions monitor medications and food inventories for some of the most recognizable names in the industries of healthcare, food service, and transportation, and logistics. See how our solutions adapt to your industry needs.
SEE SOLUTIONSCall +1 (866) 806-2653 to speak with our experts or get started with a demo.
CONTACT USSmartSense was created to use the power of the Internet of Things (IoT) to help our customers protect the assets most critical to the success of their business.
See our storyMay 17, 2017
Written by SmartSense
A big challenge for pharmaceutical companies today is monitoring the cold chain for vaccines in need of refrigeration. To make things more complicated, “colder is better” remains a common misconception among healthcare professionals when it comes to vaccine storage. In fact, accidentally over-chilling vaccines is more common than you may think and can result in the loss of money and time spent implementing revaccination programs.
Unfortunately, U.S. agencies do not require rigorous regulations for monitoring vaccine temperatures. That’s why leaders in the health system need to educate all stakeholders throughout the cold chain about the consequences of inconsistent temperatures. Only then can effective monitoring plans be put in place throughout the cold chain.
A big challenge for pharmaceutical companies today is cold chain monitoring for vaccines in need of refrigeration. To make things more complicated, “colder is better” remains a common misconception among healthcare professionals when it comes to vaccine storage. In fact, accidentally over-chilling vaccines is more common than you may think and can result in the loss of money and time spent implementing revaccination programs.
Unfortunately, U.S. agencies do not require rigorous regulations for monitoring vaccine temperatures in the cold chains. That’s why leaders in the health system need to educate all stakeholders throughout the cold chain about the consequences of inconsistent temperatures. Only then can effective monitoring plans be put in place throughout the cold chain.
The cold chain refers to the preservation of consistent temperatures for refrigerated vaccines from manufacture through delivery to healthcare facilities. During this process, stakeholders at each stop along the supply chain should monitor and maintain the vaccine’s optimal temperature range (ideally between 2°C and 8°C). The result of failing to monitor vaccine temperatures accurately—even for short periods—may result in:
A number of studies have demonstrated how cold chain operations are frequently broken in developing nations. Especially regions close to the equator, where ambient temperatures severely exceed more than 8°C. For example, a 2015 survey from Cameroon found that only 50% of vaccines needing refrigeration were regularly monitored in 81% of healthcare facilities.
Equally problematic, up to 35% of vaccines worldwide are exposed to freezing temperatures. To make matters worse, education programs to improve storage conditions for vaccines are sorely limited. In one study from India:
Beyond academic studies, the media has reported numerous instances where frozen vaccines had to be discarded and patients needed revaccination. Not surprisingly, vaccine wastage and revaccination are expensive. A U.S. survey suggested that 1%–5% of vaccines are wasted ( mostly due to cold chain damage), potentially costing up to $31 million. Most of these incidences can be avoided simply by fixing breaks in the cold chain.
Stay up-to-date on the evolution of IoT connectivity.
Learn how our complete critical environment monitoring solution will help you connect and transform your business.
Call +1 (866) 806-2653 to speak with our industry experts or get started by requesting a demo.
SCHEDULE DEMO